Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Briggs

Showing results (221-230 of 229) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 229 results.
Bioorganic & Medicinal Chemistry Letters|August 28, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxidesJavier de Vicente, Robert T Hendricks, David B Smith, et al.
Health Economics|April 21, 2023
Guidance on the use of complex systems models for economic evaluations of public health interventionsPenny R Breeze, Hazel Squires, Kate Ennis, et al.
The Lancet. Oncology|April 4, 2018
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trialTimothy J Iveson, Rachel S Kerr, Mark P Saunders, et al.
JMIR Research Protocols|January 10, 2020
Early Signs Monitoring to Prevent Relapse in Psychosis and Promote Well-Being, Engagement, and Recovery: Protocol for a Feasibility Cluster Randomized Controlled Trial Harnessing Mobile Phone Technology Blended With Peer SupportAndrew Gumley, Simon Bradstreet, John Ainsworth, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinedionesJavier de Vicente, Robert T Hendricks, David B Smith, et al.
International Journal of Epidemiology|October 21, 2024
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) studyOmer Elneima, Hamish J C McAuley, Olivia C Leavy, et al.
ERJ Open Research|October 1, 2024
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort studyOlivia C Leavy, Richard J Russell, Ewen M Harrison, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 12, 2026
Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational studyLucy E Gardiner, Daniel Lozano-Rojas, Nikki Smith, et al.
Allergy|June 9, 2020
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practiceJean Bousquet, Josep M Anto, Claus Bachert, et al.
Pageof 23

Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Bioorganic & Medicinal Chemistry Letters|August 28, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxidesJavier de Vicente, Robert T Hendricks, David B Smith, et al.
Health Economics|April 21, 2023
Guidance on the use of complex systems models for economic evaluations of public health interventionsPenny R Breeze, Hazel Squires, Kate Ennis, et al.
The Lancet. Oncology|April 4, 2018
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trialTimothy J Iveson, Rachel S Kerr, Mark P Saunders, et al.
JMIR Research Protocols|January 10, 2020
Early Signs Monitoring to Prevent Relapse in Psychosis and Promote Well-Being, Engagement, and Recovery: Protocol for a Feasibility Cluster Randomized Controlled Trial Harnessing Mobile Phone Technology Blended With Peer SupportAndrew Gumley, Simon Bradstreet, John Ainsworth, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinedionesJavier de Vicente, Robert T Hendricks, David B Smith, et al.
International Journal of Epidemiology|October 21, 2024
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) studyOmer Elneima, Hamish J C McAuley, Olivia C Leavy, et al.
ERJ Open Research|October 1, 2024
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort studyOlivia C Leavy, Richard J Russell, Ewen M Harrison, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 12, 2026
Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational studyLucy E Gardiner, Daniel Lozano-Rojas, Nikki Smith, et al.
Allergy|June 9, 2020
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practiceJean Bousquet, Josep M Anto, Claus Bachert, et al.
Pageof 23